Circle CVI Announces FDA Clearance for cvi42 | Plaque for Coronary Artery Disease Evaluation

CALGARY, Alberta, Oct. 29, 2025 (Korea Bizwire) – Circle Cardiovascular Imaging Inc. (Circle CVI), a global leader in cardiovascular imaging solutions, today announced that its cvi42 | Plaque solution has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for clinical use in the United States. This innovative, AI-enabled [...]